The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma

Clinical Nuclear Medicine

Volumn 32, Issue 9, 2007, Pages 696-699

  Fard Esfahani, Armaghan ^a   Mirshekarpour, Hossein ^a   Fallahi, Babak ^a   Eftekhari, Mohammad ^a   Saghari, Mohsen ^a   Beiki, Davood ^a   Ansari Gilani, Kianoush ^a   Takavar, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Complication; I 131; Iodine 131; Lacrimal glands; Radioiodine therapy; Thyroid cancer

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EXPOSURE; DRUG MEGADOSE; DRY EYE; EPIPHORA; FEMALE; HUMAN; LACRIMAL GLAND DISEASE; LACRIMAL GLAND FUNCTION; MALE; OCULAR PRURITUS; RISK FACTOR; SCHIRMER TEST; THYROID CARCINOMA;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; DRY EYE SYNDROMES; FEMALE; HUMANS; IODINE RADIOISOTOPES; LACRIMAL APPARATUS; MALE; MIDDLE AGED; RADIATION DOSAGE; RADIATION INJURIES; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 34548104591     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318124fdb6     Document Type: Article

References (11)

1. Carpenter CCJ, Griggs RC, Loscalzo J. Cecil Essentials of Medicine. Philadelphia: WB Saunders; 2001:555-563.
2. Cavalieri RR. Iodine metabolism and thyroid physiology: current concepts. Thyroid. 1997;7:177-181.
3. Bohuslaviziki KH, Brenner W, Lassmann S, et al. Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun. 1996;17:681-686.
4. Markitziu A, Lustmann J, Uzieli B, et al. Salivary and lacrimal gland involvement in a patient who had undergone a thyroidectomy and was treated with radioiodine for thyroid cancer. Oral Surg Oral Med Oral Pathol. 1993;75:318-322.
5. Bakheet SM, Hammami MM, Hemidan A, et al. Radioiodine secretion in tears. J Nucl Med. 1998;39:1452-1454.
6. Zetting G, Karanikas G, Hanselmayer G, et al. Radioactive contamination of contact lenses during radioiodine therapy. Nucl Med Commun. 2000;21:955-957.
7. Miller NR, Newman NJ. Walsh & Hoyt's Clinical Neuro-Ophthalmology, the Essentials. Philadelphia: Lippincott Williams and Wilkins; 1999:411-431.
8. Hay EM, Thomas E, Pal B, et al. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis. 1998;57:20-24.
9. Solans R, Bosch JA, Galofre P, et al. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42:738-743.
10. Zetting G, Hanselmayer G, Fueger BJ, et al. Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study. Eur J Nucl Med Mol Imaging. 2002;29:1428-1432.
11. Kloos RT, Duvuuri V, Jhiang SM, et al. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab. 2002;29:1428-1432.